Related Experiment Video

Updated: Aug 11, 2026

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
06:40

Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

Published on: July 28, 2023

Treatment of Helicobacter pylori gastritis improves dyspeptic symptoms in children

Aliye Uc1, Sonny K F Chong

  • 1Betton Clinic, Little Rock, Arkansas, USA. aliye-uc@uiowa.edu

Journal of Pediatric Gastroenterology and Nutrition
|April 20, 2002
PubMed

Insights

Treating Helicobacter pylori gastritis in children significantly improved dyspeptic symptoms. This study suggests H. pylori treatment is beneficial for pediatric dyspepsia, even without active ulcers.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Microbiome Research

Background:

  • Helicobacter pylori (H. pylori) treatment guidelines in adults focus on active ulcers.
  • Peptic ulcer disease prevalence is lower in children, making pediatric H. pylori treatment unclear.
  • Dyspepsia is a common symptom in children, often without identifiable organic causes.

Purpose of the Study:

  • To evaluate the efficacy of H. pylori gastritis treatment in improving dyspeptic symptoms in children.
  • To determine if H. pylori eradication benefits children with non-ulcer dyspepsia.

Main Methods:

  • Upper gastrointestinal endoscopy with biopsies for H. pylori gastritis diagnosis in 16 children with dyspepsia.
  • H. pylori eradication therapy using clarithromycin, amoxicillin, and a proton pump inhibitor for 2 weeks.
  • Dyspepsia symptom assessment via questionnaire before and after treatment, analyzed using Student t test.

Main Results:

  • All patients diagnosed with H. pylori gastritis, characterized by antral nodularity and chronic active gastritis.
  • No evidence of peptic ulcer disease was found in any patient.
  • Significant reduction in mean total dyspepsia symptom score post-treatment (12.6 to 2.1, P < 0.001).
  • Symptom improvement was sustained at long-term follow-up (9.7 months).

Conclusions:

  • Treatment of H. pylori gastritis effectively improves dyspeptic symptoms in children.
  • H. pylori eradication may be a valuable therapeutic strategy for pediatric dyspepsia.
  • Further research is warranted to establish pediatric H. pylori treatment guidelines.
Abstract

More Related Videos

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...